- Home
- NMRA vs CURV Comparison
NMRA vs CURV Comparison
Compare NMRA & CURV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMRA
- CURV
- Stock Information
- Founded
- NMRA 2019
- CURV 2001
- Country
- NMRA United States
- CURV United States
- Employees
- NMRA N/A
- CURV N/A
- Industry
- NMRA
- CURV Clothing/Shoe/Accessory Stores
- Sector
- NMRA
- CURV Consumer Discretionary
- Exchange
- NMRA Nasdaq
- CURV Nasdaq
- Market Cap
- NMRA 268.5M
- CURV 215.9M
- IPO Year
- NMRA 2023
- CURV 2021
- Fundamental
- Price
- NMRA $1.57
- CURV $1.87
- Analyst Decision
- NMRA Hold
- CURV Hold
- Analyst Count
- NMRA 8
- CURV 5
- Target Price
- NMRA $5.83
- CURV $3.09
- AVG Volume (30 Days)
- NMRA 376.3K
- CURV 1.0M
- Earning Date
- NMRA 11-11-2025
- CURV 09-04-2025
- Dividend Yield
- NMRA N/A
- CURV N/A
- EPS Growth
- NMRA N/A
- CURV N/A
- EPS
- NMRA N/A
- CURV 0.03
- Revenue
- NMRA N/A
- CURV $1,068,099,000.00
- Revenue This Year
- NMRA N/A
- CURV N/A
- Revenue Next Year
- NMRA N/A
- CURV N/A
- P/E Ratio
- NMRA N/A
- CURV $62.04
- Revenue Growth
- NMRA N/A
- CURV N/A
- 52 Week Low
- NMRA $0.61
- CURV $1.62
- 52 Week High
- NMRA $17.19
- CURV $7.19
- Technical
- Relative Strength Index (RSI)
- NMRA 46.94
- CURV 38.79
- Support Level
- NMRA $1.42
- CURV $1.80
- Resistance Level
- NMRA $1.59
- CURV $1.92
- Average True Range (ATR)
- NMRA 0.10
- CURV 0.15
- MACD
- NMRA -0.03
- CURV 0.01
- Stochastic Oscillator
- NMRA 36.14
- CURV 29.88
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
About CURV Torrid Holdings Inc.
Torrid Holdings Inc is a direct-to-consumer brand of apparel, intimates, and accessories in North America. The company is focused on fit and offers high-quality products across a broad assortment that includes tops, bottoms, denim, dresses, intimates, activewear, footwear, and accessories. The company has one reportable segment, which includes the operation of the e-commerce platform and stores. The company generates revenue from the sale of apparel, intimates, and accessories through its e-commerce platform and its store locations.